1Miettinen, TA, Gylling, H, Vanhanen, H. Serum cholesterol response to dietary cholesterol and apolipoprotein E phenotype. Lancet 1988; 2: 1261.
2Tikkanen, MJ, Huttunen, JK, Ehnholm, C, Pietinen, P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990; 10: 285–8.
3Mänttäri, M, Koskinen, P, Ehnholm, C, Huttunen, JK, Manninen, V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991; 40: 217–21.
4Lehtimäki, T, Moilanen, T, Solakivi, T, Laippala, P, Ehnholm, C. Cholesterol-rich diet changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Annals of Medicine 1992; 24: 61–6.
5Kesäniemi, YA, Ehnholm, C, Miettinen, TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. Journal of Clinical Investigation 1987; 80: 578–81.
6Lala, A, Scoppola, A, Motti, C, Caccese, D, Menzinger, G. Apolipoprotein E genotype and cholesterogenesis in polygenic hypercholesterolemia. Metabolism 1998; 47: 97–100.
7Maitland-van der Zee, AH, Klungel, OH, Stricker, BH, Verschuren, MWM, Kastelein, JJ, Leufkens, HG, et al. Genetic polymorphism: importance for response to HMG-CoA reductase inhibitors. Atherosclerosis 2002; 163: 213–22.
8Mooser, V, Waterworth, DM, Isenhour, T, Middleton, L. Cardiovascular pharmacogenetics in the SNP era. Journal of Thrombosis and Haemostasis 2003; 1: 1398–402.
9Lapinleimu, H, Viikari, J, Rönnemaa, T, Valimaki, I, Tuominen, J, Marniemi, J, et al. Apolipoprotein E polymorphism and serum lipids in a randomized, prospective trial of an infant diet with reduced saturated fat and cholesterol. Pediatrics 1996; 98: 757–62.
10Tammi, A, Rönnemaa, T, Miettinen, TA, Gylling, H, Rask-Nissila, L, Viikari, J, et al. Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: the STRIP study. Special Turku Coronary Risk Factor Intervention Project. Acta Paediatrica 2002; 91: 1155–62.
11World Health Organization (WHO). International Classification of Diseases, 1975 Revision. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death Volume 1. Geneva: WHO, 1997.
12Hixson, JE, Vernier, DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. Journal of Lipid Research 1990; 31: 545–8.
13Lopes-Virella, MF, Stone, P, Ellis, S, Colwell, JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clinical Chemistry 1977; 23: 882–4.
14Fossati, P, Prencipe, L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry 1982; 28: 2077–80.
15Assmann, G, Schriewer, H, Schmitz, G, Hagele, EO. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clinical Chemistry 1983; 29: 2026–30.
16Tietz, NW. Clinical Guide to Laboratory Tests, 2nd ed. Philadelphia, PA: WB Saunders Company, 1990.
17Friedewald, WT, Levy, R, Fredrickson, DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499–502.
18Hosmer, DW, Lemeshow, S. Applied Logistic Regression, 2nd ed. New York: John Wiley & Sons Inc., 2000.
19Salminen, M, Vahlberg, T, Ojanlatva, A, Kivelä, S-L. Effects of a controlled family-based health education/counseling intervention. American Journal of Health Behavior 2005; 29: 395–406.
20Salminen, M, Vahlberg, T, Kivelä, S-L. Effects of family-oriented risk-based prevention on serum cholesterol and blood pressure values of children and adolescents. Scandinavian Journal of Primary Health Care 2005; 23: 34–41.
21Lehtimäki, T, Moilanen, T, Aalto-Setälä, K, Kontula, K, Porkka, K, Åkerblom, HK, et al. Association of apolipoprotein E and B polymorphism with serum lipids. Annals of Medicine 1991; 23: 657–62.
22Lehtimäki, T, Porkka, K, Viikari, J, Ehnholm, C, Åkerblom, HK, Nikkari, T. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study. Pediatrics 1994; 94: 489–93.
23Parlier, G, Thomas, G, Bereziat, G, Fontaine, JL, Girardet, J. Relation of apolipoprotein E polymorphism to lipid metabolism in obese children. Pediatric Research 1997; 41: 682–5.
24Okada, T, Sato, Y, Iwata, F, Hara, M, Kim, H, Harada, K. Relationship of apolipoprotein E phenotypes to serum lipid and lipoprotein levels in Japanese schoolchildren. Acta Paediatrica. 1998; 87: 460–1.
25Bercedo-Sanz, A, Gonzáles-Lamuño, D, Málaga, S, Garcia-Fuentes, M. Impact of ApoE4 allele on total cholesterol levels of children in northern Spain. Clinical Genetics 1999; 55: 69–70.
26Couture, P, Archer, WR, Lamarche, B, Landry, N, Deriaz, O, Corneau, L, et al. Influences of apolipoprotein E polymorphism on the response of plasma lipids to the ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet. Metabolism 2003; 52: 1454–9.
27Hubacek, JA, Pitha, J, Škodová, Z, Poledne, R, Lanska, V, Waterworth, DM, et al. Polymorphism in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clinical Biochemistry 2003; 36: 263–7.
28Ishiwata, K, Homma, Y, Ishikawa, T, Nakamura, H, Handa, S. Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects. Nutrition 2002; 18: 561–5.
29Ordovás, JM. The genetics of serum lipid responsiveness to dietary interventions. Proceedings of the Nutrition Society 1999; 58: 171–87.
30Dixon, LB, Shannon, BM, Tershakovec, AM, Bennett, MJ, Coates, PM, Cortner, JA. Effects of family history of heart disease, apolipoprotein E phenotype, and lipoproteina on the response of children's plasma lipids to change in dietary lipids. American Journal of Clinical Nutrition 1997; 66: 1207–17.
31Puska, P, Vartiainen, E, Pallonen, U, Salonen, JT, Poyhia, P, Koskela, K. The North Karelia Youth Project: evaluation of two years of intervention on health behavior and CVD risk factors among 13- to 15-year old children. Preventive Medicine 1982; 11: 550–70.
32Vartiainen, E, Puska, P, Pietinen, P, Nissinen, A, Leino, U, Uusitalo, U. Effects of dietary fat modifications on serum lipids and blood pressure in children. Acta Paediatrica Scandinavica 1986; 75: 396–401.
33Porkka, KVK, Viikari, JSA, Rönnemaa, T, Marniemi, J, Åkerblom, HK. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study. Acta Paediatrica 1994; 83: 838–48.